Product NDC: | 10019-120 |
Proprietary Name: | Esmolol Hydrochloride |
Non Proprietary Name: | Esmolol Hydrochloride |
Active Ingredient(s): | 10 mg/mL & nbsp; Esmolol Hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10019-120 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019386 |
Marketing Category: | NDA |
Start Marketing Date: | 19861231 |
Package NDC: | 10019-120-01 |
Package Description: | 25 VIAL in 1 CARTON (10019-120-01) > 10 mL in 1 VIAL (10019-120-39) |
NDC Code | 10019-120-01 |
Proprietary Name | Esmolol Hydrochloride |
Package Description | 25 VIAL in 1 CARTON (10019-120-01) > 10 mL in 1 VIAL (10019-120-39) |
Product NDC | 10019-120 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Esmolol Hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19861231 |
Marketing Category Name | NDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | ESMOLOL HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |